<!DOCTYPE html>
<html>
    <head>
        <!-- Google tag (gtag.js) -->
        <script async src="https://www.googletagmanager.com/gtag/js?id=G-TJH2RE0DE4"></script>
        <script>
            window.dataLayer = window.dataLayer || [];
            function gtag(){dataLayer.push(arguments);}
            gtag('js', new Date());

            gtag('config', 'G-TJH2RE0DE4');
        </script>    

        <title>Prostate Results</title>
        <meta charset="UTF-8">
        <meta name="description" content="Prostate risk results">
        <meta name="author" content="Xavier Orcutt">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">
    
        <link rel="stylesheet" type="text/css" href="../../static/css/mystyle.css">
        <script src="../../static/scripts/myscripts.js"></script> 
    </head>
    
    <body>
        
        <!-- HEADER -->
        <header>
            <h1>Prostate Results</h1>
        </header>

        <!-- <p>This patient's estimated median overall survival: <span class="med_surv_estimate"> {{ med_surv_est }} days </span></p> -->

        <p>Survival data for potentially relevant therapies, based on this patient's biomarker profile, are shown below.</p>
        
        <!-- CASTRATE SENSITIVE -->
        {% if bio_status == "hspc" %}

        <!-- CASTRATE SENSITIVE: CHAARTED -->
        <div class="section-box">
            <p class="treatment">First-line docetaxel plus ADT or ADT</p>

            <p><span class="risk-benefit">Compared to other patients who received these therapies, this patient's risk phenotype is:</span> {{ chaarted_risk }} </p>
            
            {% if chaarted_risk == "Low" %}
            <p><span class="risk-benefit">Based on the patient's risk phenotype, is docetaxel plus ADT expected to offer a survival advantage over ADT alone?</span> No</p>

            <p>Click below for more information on real-world overall survival (OS) and how it compares to patients in the <a href = "https://www.nejm.org/doi/full/10.1056/nejmoa1503747">CHAARTED</a> trial:</p>
            <div class="collapsible">
                <button class="collapsible-button">OS estimates</button>
                <div class="content">
                    <img src="../../static/images/prostate/chaarted_low.png">
                </div>
            </div>
        
            {% elif chaarted_risk == "Medium" %}
            <p><span class="risk-benefit">Based on the patient's risk phenotype, is docetaxel plus ADT expected to offer a survival advantage over ADT alone?</span> Yes</p>

            <p>Click below for more information on real-world overall survival (OS) and how it compares to patients in the <a href = "https://www.nejm.org/doi/full/10.1056/nejmoa1503747">CHAARTED</a> trial:</p>
            <div class="collapsible">
                <button class="collapsible-button">OS estimates</button>
                <div class="content">
                    <img src="../../static/images/prostate/chaarted_med.png">
                </div>
            </div>
       
            {% elif chaarted_risk == "High"%}
            <p><span class="risk-benefit">Based on the patient's risk phenotype, is docetaxel plus ADT expected to offer a survival advantage over ADT alone?</span> Yes</p>

            <p>Click below for more information on real-world overall survival (OS) and how it compares to patients in the <a href = "https://www.nejm.org/doi/full/10.1056/nejmoa1503747">CHAARTED</a> trial:</p>
            <div class="collapsible">
                <button class="collapsible-button">OS estimates</button>
                <div class="content">
                    <img src="../../static/images/prostate/chaarted_high.png">
                </div>
            </div>
            {% endif %}
        
            <div class="collapsible">
                <button class="collapsible-button">RCT comparison</button>
                <div class="content">
                    <img src="../../static/images/prostate/chaarted_summary.png">
                </div>
            </div>
        </div>

        <div class="space-result"></div>

        <!-- CASTRATE SENSITIVE: LATITUDE -->
        <div class="section-box">
            <p class="treatment">First-line abiraterone plus ADT or ADT</p>

            <p><span class="risk-benefit">Compared to other patients who received these therapies, this patient's risk phenotype is:</span> {{ latitude_risk }} </p>

            {% if latitude_risk == "Low" %}
            <p><span class="risk-benefit">Based on the patient's risk phenotype, is abiraterone plus ADT expected to offer a survival advantage over ADT alone?</span> No</p>

            <p>Click below for more information on real-world overall survival (OS) and how it compares to patients in the <a href = "https://www.nejm.org/doi/full/10.1056/nejmoa1704174">LATITUDE</a> trial:</p>
            <div class="collapsible">
                <button class="collapsible-button">OS estimates</button>
                <div class="content">
                    <img src="../../static/images/prostate/latitude_low.png">
                </div>
            </div>
        
            {% elif latitude_risk == "Medium" %}
            <p><span class="risk-benefit">Based on the patient's risk phenotype, is abiraterone plus ADT expected to offer a survival advantage over ADT alone?</span> No</p>

            <p>Click below for more information on real-world overall survival (OS) and how it compares to patients in the <a href = "https://www.nejm.org/doi/full/10.1056/nejmoa1704174">LATITUDE</a> trial:</p>
            <div class="collapsible">
                <button class="collapsible-button">OS estimates</button>
                <div class="content">
                    <img src="../../static/images/prostate/latitude_med.png">
                </div>
            </div>
       
            {% elif latitude_risk == "High"%}
            <p><span class="risk-benefit">Based on the patient's risk phenotype, is abiraterone plus ADT expected to offer a survival advantage over ADT alone?</span> No</p>

            <p>Click below for more information on real-world overall survival (OS) and how it compares to patients in the <a href = "https://www.nejm.org/doi/full/10.1056/nejmoa1704174">LATITUDE</a> trial:</p>
            <div class="collapsible">
                <button class="collapsible-button">OS estimates</button>
                <div class="content">
                    <img src="../../static/images/prostate/latitude_high.png">
                </div>
            </div>
            {% endif %}
        
            <div class="collapsible">
                <button class="collapsible-button">RCT comparison</button>
                <div class="content">
                    <img src="../../static/images/prostate/latitude_summary.png">
                </div>
            </div>
        </div>
        {% endif %}

        <!-- CASTRATE RESISTANt -->
        {% if bio_status == "crpc" %}
        <div class="section-box">
            <p class="empty">No treatment survival estimates are available for patients with castrate-resistant disease.</p>
        </div>
        {% endif %}

        <div class="space-result"></div>
        <button class="back-button" onclick="window.location.href='/prostate'">Back to form</button>
        <button class="home-button" onclick="window.location.href='/'">Home</button>
        <script src="../../static/scripts/myscripts.js"></script>

    </body>
</html>
      

